AE-19-ZK31_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, Prinomastat, Angiogenesis Inhibitors;MMP-9 (Gelatinase B) Inhibitors;MMP-2 (Gelatinase A) Inhibitors targeting MMP2, MMP9, MMP14, MMP11, MMP15, MMP16, MMP17, MMP19, MMP23A, MMP20, MMP27, MMP28, MMP21 (Novartis, 466151)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/466151
Similar Terms
Downloads & Tools

Genes

15 genes differentially expressed following the AE-19-ZK31_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
TMEM258 transmembrane protein 258 0.616298
RPS13 ribosomal protein S13 0.488256
RPL37 ribosomal protein L37 0.358123
RHOG ras homolog family member G 0.283666
RNASEH2C ribonuclease H2, subunit C 0.272619
ATP5PO ATP synthase peripheral stalk subunit OSCP 0.262609
LGALS1 lectin, galactoside-binding, soluble, 1 0.262609
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 0.262609
ELOB elongin B 0.262609
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.245727
UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 0.208452
RPL19 ribosomal protein L19 0.201493

decreased expression

Symbol Name Standardized Value
CLSTN3 calsyntenin 3 -0.209708
CKAP5 cytoskeleton associated protein 5 -0.206627
PKM pyruvate kinase, muscle -0.205046